3 studies found for: "Multiple endocrine neoplasia type 2"
|1||Not yet recruiting||
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
|2||Active, not recruiting||
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
† Indicates status has not been verified in more than two years